Datameds AI, Inc. balance sheet

At the end of fiscal 2025, Datameds AI, Inc. had total assets of $30.5m, total liabilities of $42.9m and shareholders' equity of −$12.4m. It held $42,571 in cash against $23.5m of debt: net debt of $23.4m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Datameds AI, Inc.: balance sheet, annual
Fiscal year	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash and equivalents	1	0	2
Receivables	—	1	1
Inventory	10	2	2
Total current assets	15	3	6
Goodwill	16	14	14
Total assets	57	30	33
Total current liabilities	38	30	39
Short-term debt	12	11	19
Long-term debt	11	13	13
Total debt	23	23	41
Total liabilities	51	43	52
Shareholders' equity	7	−12	−20
Net debt (negative = net cash)	22	23	38
Shares outstanding	51m	—	3m

US$ millions unless shown otherwise. Fiscal quarters.

Datameds AI, Inc.: balance sheet, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	—	—	—	—	—	1	1	1
Inventory	—	10	10	9	7	2	2	2
Total current assets	—	15	17	14	13	3	3	6
Goodwill	—	16	16	16	16	14	14	14
Total assets	—	57	58	54	53	30	30	33
Total current liabilities	—	38	46	42	33	30	32	39
Short-term debt	—	12	18	13	12	11	15	19
Long-term debt	—	11	24	10	13	13	13	13
Total debt	—	23	42	23	25	23	28	32
Total liabilities	—	51	54	53	46	43	45	52
Shareholders' equity	10	7	4	1	7	−12	−15	−20
Shares outstanding	—	51m	61m	63m	89m	2m	119m	3m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: MEDS vs MNDR DRIO vs MEDS MEDS vs WORX

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Datameds AI, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Datameds AI, Inc.